Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta‐Analysis
Head & Neck · 2025-05 · 47 (5) · 1541-1553
DOI: 10.1002/hed.28132 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Head & Neck, online erschienen am 18.03.2025. Verfasst von Luccas Lavareze und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Head and Neck Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Adenoid cystic carcinoma (ACC) is a slow‐growing tumor with variable outcomes, making follow‐up protocols challenging. This review analyzed outcomes in ACC, focusing on patterns and factors related to adverse prognoses.
Methods
A search was conducted on March 25, 2024, in MEDLINE, PubMed, Scopus, and EMBASE. Studies analyzing ACC survival were included, while those lacking these data or focusing on a single ACC site were excluded. The Joanna Briggs Institute's Critical Appraisal tool was used to assess the risk of bias, and the metanalysis was performed using R software.
Results
Among 57 studies (17 497 patients), ACC predominantly affected women (mean age: 52.69 years) and occurred mainly in minor salivary glands. Distant metastasis was the most frequent adverse outcome, occurring at 34.8 months on average. Locoregional metastasis and local recurrence occurred at 27.5 and 31.3 months, respectively. Five‐, 10‐, 15‐, and 20‐year survival rates were 73.8%, 48.5%, 42.3%, and 26.5%, respectively. Poor survival predictors included advanced T stage, positive lymph nodes, solid tumors, distant metastasis, and positive surgical margins.
Conclusions
Distant metastasis is the most frequent adverse outcome in ACC, and prognostic factors are related to advanced and residual tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.
- Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
- Biorepository and Molecular Pathology, Huntsman Cancer Institute, University of Utah (UU), Salt Lake City, Utah, USA.
ORCID-Profile: Luccas Lavareze, Talita de Carvalho Kimura, Reydson Alcides de Lima-Souza, Erika Said Abu Egal, Fernanda Viviane Mariano
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Lavareze, L., Kimura, T. C., Cacita, N., de Lima-Souza, R. A., Cattan, M. E. S., Egal, E. S. A., Altemani, A., & Mariano, F. V. (2025). Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta‐Analysis. Head & Neck, 47(5), 1541-1553. https://doi.org/10.1002/hed.28132
Vancouver
Lavareze L, Kimura TC, Cacita N, de Lima-Souza RA, Cattan MES, Egal ESA, et al. Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta‐Analysis. Head & Neck. 2025;47(5):1541-1553. doi:10.1002/hed.28132
BibTeX
@article{Lavareze2025,
author = {Lavareze, Luccas and Kimura, Talita de Carvalho and Cacita, Nádia and de Lima-Souza, Reydson Alcides and Cattan, Marcelo Elias Schempf and Egal, Erika Said Abu and Altemani, Albina and Mariano, Fernanda Viviane},
title = {Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta‐Analysis},
journal = {Head & Neck},
year = {2025},
volume = {47},
number = {5},
pages = {1541--1553},
doi = {10.1002/hed.28132}
}
EUVIMED